This post is the third in our larger series, Industry Insider Interviews. Read our previous posts, featuring Ed Potero of Biogen and Dagmara Kulis of EORTC. YP: What type of trends are you seeing related to eCOA? Jessica: The major trend we’ve seen in…
Dagmara Kulis, Translation Team Lead, EORTC This post is the second in our larger series, Industry Insider Interviews. Read our previous post, featuring Ed Potero of Biogen, here. Tell me about what you do at EORTC, and how long you’ve been in your role? DK: I am a translator by training with a Master’s…
Ed Potero, Senior Manager, Biometrics Operations – eCOA Lead This post is the first in our larger series, Industry Insider Interviews. YPrime: Tell us about your background as it relates to eCOA EP: I’ve been involved with eCOA and similar technologies since 2000. I worked for an eCOA provider when eCOA consisted of basic…
Mark Maietta, Chief Commercial Officer Last week, YPrime brought a mix of eCOA experts together to offer perspectives and insight from their experiences during a live panel discussion, entitled The Future of eCOA. Moderated by Lisa Henderson, Editor for Applied Clinical Trials, panelists included Ken Grice, eCOA Strategist for Bayer and Jonathan Helfgott, Executive Director…
Bryan Clayton, Vice President, Strategic Solutions YPrime recently sponsored OCT East Coast, a two-day event that brought together sponsors, CROs and eclinical service providers for interactive discussions on outsourcing, clinical operations, clinical innovation and trial technology. If you missed the event, read our summary below for event highlights. Across the clinical development spectrum, a few…
Colin Cleary, Vice President, Strategic Solutions Although adaptive testing has been widely adopted across a variety of industries for decades, it has only recently made its way into the clinical trial space. Based on item response theory (or IRT for short… not to be confused with interactive response technology, a topic we discuss frequently here),…
This post is the fourth update in our larger series, The Art and Science of Successful eClinical Project Delivery. Read the previous posts here: eClinical Project Management, Why We Love UAT, and Customer Focus. Ask any customer about important eClinical provider attributes and nearly all of them will quickly speak to the criticality of helpdesk…
This post is the third update in our larger series, The Art and Science of Successful eClinical Project Delivery. Read our previous posts on user acceptance testing and project management. As a seasoned clinical trial professional, my guiding philosophy for project success can be summed up simply: “If you focus on the customer throughout…
How many times have you heard anyone on a clinical project team profess to love user acceptance testing (UAT)? Probably never. For many clinical research professionals, UAT is often the least anticipated event of the study start-up phase. It’s often associated with unwanted surprises or viewed as a necessary evil.
So many things impact the success of eClinical implementation. It’s a mix of broad expertise, robust technology, commitment to service, combined with flexible and often creative solutions. In short, it takes art and science to get the job done effectively. The first post in our blog series, The Art and Science of Successful eClinical…
